Gene-Edited Future? Sam Altman’s Preventive Bet Reignites Fears of ‘Designer Babies’
OpenAI CEO Sam Altman and his husband Oliver Mulherin have quietly entered one of the most controversial frontiers in modern science: embryo gene editing. Their investment in a startup called Preventive has...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.